EMA Explains Process For Assessing Suitability Of Biomarkers With Concerned Medicines
Executive Summary
A new EU guideline outlines the steps that notified bodies can take to facilitate the European Medicines Agency’s assessment of the appropriateness of a companion diagnostic’s use with a drug.
You may also be interested in...
Global Medtech Guidance Tracker: March 2023
Stay current on regulatory guidelines from around the world with Medtech Insight's Guidance Tracker. Forty-four documents have been posted on the tracker since its last update.
Final ICH Guide Supports Nonclinical Development Of Gene Therapy Products
The International Council for Harmonisation has finalized guidance that aims to facilitate the nonclinical and clinical development programs of gene therapy products, while avoiding the unnecessary use of animals.
High Ambitions For EU DARWIN Platform After Delivery Of First RWE Studies
Within one year of its establishment, DARWIN EU has started reaping benefits for EU drug regulators commissioning studies using real-world data to better understand diseases, populations and the uses and effects of medicines. The studies can be performed faster, cheaper and at increased capacity.